Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

INVO Fertility (IVF) Preferred Stock Liabilities (2024 - 2025)

INVO Fertility (IVF) has disclosed Preferred Stock Liabilities for 2 consecutive years, with $4.0 million as the latest value for Q1 2025.

On a quarterly basis, Preferred Stock Liabilities changed N/A to $4.0 million in Q1 2025 year-over-year; TTM through Mar 2025 was $4.0 million, a N/A change, with the full-year FY2024 number at $7.5 million, changed N/A from a year prior.
Preferred Stock Liabilities was $4.0 million for Q1 2025 at INVO Fertility, down from $7.5 million in the prior quarter.
In the past five years, Preferred Stock Liabilities ranged from a high of $7.5 million in Q4 2024 to a low of $4.0 million in Q1 2025.